Individuals with aggressive non-Hodgkin lymphoma and those with limited-stage Hodgkin lymphoma who underwent PET/CT-guided therapy had reduced one-year mortality, compared with those who had CT-guided treatment only, but those with HL had similar one-year outcomes, Canadian researchers reported in a radiology journal. The findings prompted researchers to suggest the association between PET-directed patient management and improved overall outcomes among those with ANHL.
Better survival in aggressive NHL found with PET/CT-guided treatment
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.